News Focus
News Focus
Followers 11
Posts 1348
Boards Moderated 0
Alias Born 12/13/2004

Re: neuroinv post# 19273

Thursday, 07/31/2008 10:58:23 AM

Thursday, July 31, 2008 10:58:23 AM

Post# of 57816
Since this may be Stoll’s last hurrah, he wants to leave with style. What better way than to present strong evidence of efficacy? Even if COR has all the data it needs for a pr release right now, who is going to complain if it is delayed by a few days? An excuse can always be made if there is a complaint to the SEC. But, come on, who would?



Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today